Johnson & Johnson Company Profile

Johnson & Johnson (JNJ) is a large cap multinational corporation trading on NYSE, part of the health care sector. The company is divided into three major divisions: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson (JNJ) manages 250 operating companies and franchises in 60 countries and is the second largest manufacturer of health care products. This company owns the Tylenol, Band-Aid and Neutrogena brands. Employing 115,500 people, the largest

» Read More About Johnson & Johnson

Related Healthcare and Pharmaceuticals Companies

Tenet Healthcare	45.81	122,616
United Therapeutics Del	65.67	17,094
Mednax	92.19	19,140
Thermo Fisher Scientific	86.14	188,846
Boston Scientific	9.535	1,445,996

Above is a small selection of related companies to Johnson & Johnson which compete alongside JNJ within the Healthcare and Pharmaceuticals sector.

Online News For Johnson & Johnson

Johnson & Johnson buys Aragon for $650M or more - USA TODAY Tue, 18 Jun 2013 13:31NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson said Monday it has agreed to buy Aragon Pharmaceuticals Inc. for at least $650 million in cash, boosting its position in prostate drug development. The privately held San Diego company is focused on the ...

Johnson & Johnson to Buy Aragon Pharmaceuticals for $650 Million Up Front - DailyFinance Tue, 18 Jun 2013 10:56The board of privately held Aragon Pharmaeuticals, a firm that concentrates on the development of hormonally based cancer treatments, has agreed to be acquired by Johnson & Johnson for an upfront cash payment of $650 million, Johnson & Johnson and ...

Johnson & Johnson to buy Aragon for up to $1 billion - Economic Times Mon, 17 Jun 2013 12:31Johnson & Johnson said on Monday that it would buy Aragon Pharmaceuticals, a private company that is running a mid-stage clinical trial for a prostate cancer drug, for $650 million in cash upfront and a possible second payment of $350 million if it ...

Option Trends: Johnson & Johnson (JNJ), General Motors (GM), and Nokia ... - Schaeffers Research Tue, 18 Jun 2013 16:28Speculative players have been taking sides on blue chip Johnson & Johnson (NYSE:JNJ), automaker General Motors Company (NYSE:GM), and Finnish telecom concern Nokia Corporation (ADR) (NYSE:NOK), according to data from the major options ...

Johnson & Johnson Announces Definitive Agreement To Acquire Aragon ... - PR Newswire (press release) Mon, 17 Jun 2013 12:02NEW BRUNSWICK, N.J., June 17, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today a definitive agreement to acquire Aragon Pharmaceuticals, Inc., a privately-held, pharmaceutical discovery and development company focused on ...

J&J in $1 billion deal to bolster prostate-cancer focus - Reuters Mon, 17 Jun 2013 22:11(Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ...

JNJ Chart

Want To Add This Quote To Your Site?

With our stock widgets you can add a real time Johnson & Johnson quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for JNJ to choose from. Visit here to build your stock quote widget »